How Can We Help?
Isepamicin (also Isepamycin) is an aminoglycoside antibiotic.
It was patented in 1973 and approved for medical use in 1988.[1] It has been identified by the World Health Organization as a Critically Important Antimicrobial for human use.[2]
Synthesis
![](https://upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Isepamicin_synthesis.svg/500px-Isepamicin_synthesis.svg.png)
Gentamicin B [36889-15-3] (1) benzyl N-[(2S)-3-(2,5-dioxopyrrolidin-1-yl)-2-hydroxy-3-oxopropyl]carbamate, PC70561099 (2) (3)
References
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 508. ISBN 9783527607495.
- ^ "Critically important antimicrobials for human medicine" (PDF). World Health Organization. 2012.
- ^ Serradell, MN; Blancafort, P.; Roberts, PJ; Castaer, J.; SCH-21420. Drugs Fut 1979, 4, 7, 525.
- ^ John J. Wright, U.S. patent 4,029,882 (1977 to Merck Sharp and Dohme Corp).
Recent Comments